Law channel feed – Endpoints News

Law channel feed

US warns drugmakers against misrepresenting cost of imported products

Yesterday

Federal judge extends order blocking RFK Jr. from reorganizing HHS

Yesterday

House passes Trump tax bill with PBM and orphan drug reforms included

2 days ago

Teva, Novartis get fresh warnings from FTC over Orange Book patent listings

3 days ago

Updated: Trump administration reveals 'most favored nation' drug price country targets

4 days ago

HHS can require approval for drugmakers to apply 340B rebate models, court rules

Last week

Amarin calls Hikma's drug label arguments 'idiosyncratic,' urges high court to decline case

Last week

Regeneron scores $400M+ jury win in Amgen cholesterol drug spat

Last week

CRISPR patent spat revived by federal appeals court ruling

Last week

HHS focuses on 'transparency' in third-round IRA negotiation guidance

Last week

Lack of detail in Trump's drug price plan raises more questions than answers

Last week

PBM overhaul and drug price negotiations make the cut in Republicans' tax bill

Last week

AstraZeneca loses appeals court fight over IRA drug price negotiations

3 weeks ago

Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling

3 weeks ago

Compounders just lost their case to put obesity drug tirzepatide back in shortage

3 weeks ago

States sue US over plan for reorganization of federal health agencies

3 weeks ago

Exclusive: SEC expected to drop investigation of Illumina's $8B Grail deal

3 weeks ago

BeiGene scores a win from US Patent Office in spat over Brukinsa

4 weeks ago

Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments

4 weeks ago

AstraZeneca posts another Truqap study fail, says China import tax could triple

4 weeks ago

New House bill would cut tax deductions pharma companies receive for ads

4 weeks ago

Compounding pharmacies dealt a blow in fight over end of semaglutide shortage

5 weeks ago

Halozyme sues Merck, alleging injectable Keytruda will infringe its patents

5 weeks ago

Top pharma companies increased lobbying spend in first quarter of 2025

Last month

12 3 4 Next page Last page